| Product Code: ETC7655004 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel`s live biotherapeutic products and microbiome CDMO import shipments continue to show high concentration with top exporters being Switzerland, USA, Germany, China, and Belgium in 2024. Despite a negative CAGR from 2020 to 2024, there was a promising growth rate of 8.63% from 2023 to 2024. This indicates a potential shift in the market dynamics and a positive outlook for the industry in Israel in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Live Biotherapeutic Products And Microbiome CDMO Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Live Biotherapeutic Products And Microbiome CDMO Market - Industry Life Cycle |
3.4 Israel Live Biotherapeutic Products And Microbiome CDMO Market - Porter's Five Forces |
3.5 Israel Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Israel Live Biotherapeutic Products And Microbiome CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Growing awareness about the importance of microbiome in maintaining health and treating diseases |
4.2.3 Technological advancements in live biotherapeutic products and microbiome research |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for live biotherapeutic products |
4.3.2 Limited understanding of the mechanisms of action and long-term effects of microbiome-based therapies |
5 Israel Live Biotherapeutic Products And Microbiome CDMO Market Trends |
6 Israel Live Biotherapeutic Products And Microbiome CDMO Market, By Types |
6.1 Israel Live Biotherapeutic Products And Microbiome CDMO Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Israel Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Application, 2022 - 2032F |
6.1.3 Israel Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By C.difficle, 2022 - 2032F |
6.1.4 Israel Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Crohns disease, 2022 - 2032F |
6.1.5 Israel Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By IBS, 2022 - 2032F |
6.1.6 Israel Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.1.7 Israel Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Others, 2022 - 2032F |
7 Israel Live Biotherapeutic Products And Microbiome CDMO Market Import-Export Trade Statistics |
7.1 Israel Live Biotherapeutic Products And Microbiome CDMO Market Export to Major Countries |
7.2 Israel Live Biotherapeutic Products And Microbiome CDMO Market Imports from Major Countries |
8 Israel Live Biotherapeutic Products And Microbiome CDMO Market Key Performance Indicators |
8.1 Number of clinical trials and research studies focusing on live biotherapeutic products and microbiome therapies |
8.2 Level of investment and funding in the development of microbiome-based products |
8.3 Adoption rate of live biotherapeutic products and microbiome therapies in healthcare settings |
9 Israel Live Biotherapeutic Products And Microbiome CDMO Market - Opportunity Assessment |
9.1 Israel Live Biotherapeutic Products And Microbiome CDMO Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Israel Live Biotherapeutic Products And Microbiome CDMO Market - Competitive Landscape |
10.1 Israel Live Biotherapeutic Products And Microbiome CDMO Market Revenue Share, By Companies, 2025 |
10.2 Israel Live Biotherapeutic Products And Microbiome CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here